LINQ™ insertable cardiac monitoring system
Centered around you
Delivering data you can trust, whilst driving efficiencies at every step of the path to diagnosis.1-29
For syncope and cryptogenic stroke patients.
Reveal LINQ™ and LINQ II™
insertable cardiac monitors
Capture meaningful moments with confidence
A highly sensitive device ensures you don’t miss critical events.
With over 20% higher detection sensitivity compared to other recently published ICMs,** and with the lowest non-actionable alerts on the market,31 the LINQ portfolio with AccuRhythm AI delivers the highest absolute detection sensitivity of 98.9% whilst filtering out false positives.**1-17
Join a live rRdcliffe webinar:
Are all ICMs created equal?
The real-world impact of cardiac diagnostic sensitivity in the age of AI.
6 May 2025 | 6.00 PM CET
Did you know that reducing false positives can come at the cost of sensitivity?
Watch Dr. Santini and Dr. Witte as they discuss the latest insights on ICM performance, the risks of compromising on sensitivity and how high detection accuracy improves clinical decisions.
Dr. Luca Santini
Consultant Cardiologist
Prof. Klaus Witte
Consultant Cardiologist
Alphons Vincent
Medical Affairs Director, Medtronic
Grant Neitzell
Engeneering Director, Medtronic
The world’s first AI platform for ICM applies AI algorithms to data flowing into the CareLinkTM Network; significantly reducing AF and pause false alerts, without compromising sensitivity.16, 23-24,30
Enables on-going innovation, as future AI releases can be applied to already implanted Reveal LINQTM and LINQ IITM ICMs via cloud-based updates.
An intuitive app-based programmer for all ICM set-up and management needs; from ICM programming, remote monitoring enrollment, technical support and patient education.
Everything is done via a tablet, simplifying workflow and saving time.19
A user-friendly patient monitor sends data from the ICM to the patient’s clinic.
And for LINQ II™, depending on level of comfort with technology and how much time is spent away from home, patients have a choice of an app or bedside monitor.
Our patient telephone support service frees up clinic time by providing answers to patient ICM and monitoring questions.20-21
For LINQ II™, our experienced team also helps patients onboard with their optimal monitoring solution.
Complete device data can be accessed via CareLink remote monitoring network, replacing the need for face-to-face follow-up and enabling faster diagnosis.22
The CareLink Network provides clear ECGs on the Quick Look reports using high-resolution graphics without compromising on ECG morphology. Experience the Interactive ECG Viewer for a precise and user-friendly ECG analysis allowing you to zoom, measure and annotate.
And for LINQ IITM, if changes to device settings need to be made after implant, it can be re-programmed remotely via CareLink™, saving both clinical and patient time.2,29
Staffed with certified ECG device specialists and cardiologists, our service filters out non-actionable transmissions and alerts you to only the 20% of data that requires clinical action.25-26
Freeing up time for you to concentrate on the patients who need it most.25-28
* Disclaimer: A controlled, head-to-head study evaluating the comparative performance of these devices has not been done.
** Comparison between Medtronic LINQ™ family of ICMs with Abbot Assert-IQ published AF sensitivity (3-7). A controlled head-to-head study evaluating the comparative sensitivity performance of device algorithms has not been done.
References
1
Reveal LINQ LNQ11 ICM Clinician Manual. M958488A001 D
2
LINQ II LNQ22 ICM Clinician Manual. M027638C001 REV B
3
Assert-IQ Model DM5000 Model DM5300 Model DM5500 User's Manual, 2024.
4
Quartieri F, Cauti F, Calo L, et al. Retrospective analysis of Confirm Rx SharpSense Technology using Real-World Data from the SMART Registry. Presented at Asia Pacific Heart Rhythm Society (APHRS); Bangkok, Thailand; Oct 27–29, 2019.
5
Gardner RS, Quartieri F, Betts TR, et al. Reducing the electrogram review burden imposed by insertable cardiac monitors. J Cardiovasc Electrophysiol. April 2022;33(4):741-750.
6
Gopinathannair R, LakkireddyD, ManyamH, et al. Improving the Specificity of Atrial Fibrillation and Tachycardia Detection in an Insertable Cardiac Monitor. Presented at Heart Rhythm Society (HRS); April 29–May 1, 2022; San Francisco, CA.
7
LUX-Dx User’s Manual, 2020
8
Pürerfellner H, Sanders P, Sarkar S, et al. Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors. Europace. November 1, 2018;20(FI_3):f321-f328.
9
Nölker G, Mayer J, Boldt L, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophysiol. December 2016;27(12):1403-1410.
10
Confirm Rx™ ICM K163407 FDA Clearance Letter. 2017.
11
Confirm Rx ICM K182981 FDA Clearance Letter. 2019.
12
Jot Dx™ ICM K212206 FDA Clearance Letter. 2021.
13
BIOTRONIK BIOMONITOR III. K190548 FDA Clearance. 2019. Technical Manual, 2020.
14
BIOTRONIK BIOMONITOR IIIm. K201865 FDA Clearance. 2020. Technical Manual, 2020.
15
Lux-Dx™ ICM K212206 FDA Clearance Letter. 2020. Technical Manual, 2020.
16
AccuRhythm™ Clinician Manual Supplements M015316C001 and M015314C001
17
ICM Published Accuracy Comparison Guide. 2021.
18
Medtronic RevealTM ICM family data. Data on file 2022.
19
Seiler A, et al. Clinic time required for remote and in-person management of patients with cardiac devices: Time and motion workflow evaluation. JMIR Cardio. 2021;5(2):e27720.
20
BeConnected Day to Day Service - Call Time Analysis. June 2022. Medtronic Data On File
21
BeConnected Onboarding Pilot Results - based on 104 patients. December 2020. Medtronic Data on File.
22
Drak-Hernández Y et al. Effectiveness and safety of remote monitoring of patients with an implantable loop recorder. Rev Esp Cardiol (Engl Ed). 2013;66(12):943-8.
23
Cheng YJ Ousdigian, KT, Koehler J, Cho YK, Kloosterman M. Innovative Artificial Intelligence Application Reduces False Pause Alerts while Maintaining. Perfect True Pause Sensitivity for Insertable Cardiac Monitors. Presented at Heart Rhythm Society Conference 2021. Published online August 1, 2021.
24
Radtke, A, et al. Artificial Intelligence Enables Dramatic Reduction of False Atrial Fibrillation Alerts from Insertable Cardiac Monitors. Presented HRS 2021.
25
Cronin, Edmond M., et al. "Remote monitoring of cardiovascular devices: a time and activity analysis." Heart Rhythm 9.12 (2012): 1947-1951.
26
Giannola, Gabriele, et al. "Outsourcing the remote management of cardiac implantable electronic devices: medical care quality improvement project." JMIR cardio 3.2 (2019): e9815.
27
Seiler A, et al. Clinic time required for remote and in-person management of patients with cardiac devices: Time and motion workflow evaluation. JMIR Cardio. 2021;5(2):e27720
28
Nicolle E, et al. Clinic time required to manage remote monitoring of cardiac implantable electronic devices: impact of outsourcing initial data review and triage. EP Europace. 2021;23(Supplement_3):euab116-519.
29
Seiler A., et al. Utilization of Remote Reprogramming to Manage Insertable Cardiac Monitor Arrhythmia Alert Burden. J Cardiovasc Electrophysiol, 2024. 30 Radtke A, Ousdigian K, Koehler J, Margetta J, Han J K. AI Enables Significant Reduction of Clinic Review Burden for Legacy ICMs. Presented HRS 2024, Boston, MA
30
Radtke A, Ousdigian K, Koehler J, Margetta J, Han J K. AI Enables Significant Reduction of Clinic Review Burden for Legacy ICMs. Presented HRS 2024, Boston, MA.
31
Kabra R, Colombowala IK, Margetta J, et al. Impact of Artificial Intelligence-enhanced Implantable Loop Recorders on Non-actionable Alert Volume and Clinic Workload in Remote Monitoring. Heart Rhythm 2024;21(Suppl. 5):S85–S86. Presented at the Heart Rhythm Congress, Boston, MA, May 16-19, 2024.
Brief statement
The material on this website should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s).
Please note that the intended use of a product may vary depending on geographical approvals.
See the device manual(s) for detailed information regarding the intended use, the (implant) procedure, indications, contraindications, warnings, precautions, and potential adverse events.
For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI. If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com.
Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser. Medtronic products placed on European markets bear the CE mark and the UKCA mark (if applicable).
For any further information, contact your local Medtronic representative.
